Wy 23205, a new non-steroidal anti-inflammatory agent.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D001920:Bradykinin / Q000037:antagonists & inhibitors; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006168:Guinea Pigs; D006614:Hindlimb; D066298:In Vitro Techniques; D007213:Indomethacin / Q000627:therapeutic use; D007249:Inflammation / Q000139:chemically induced; D010080:Oxazoles / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use*; D051381:Rats
D000893:Anti-Inflammatory Agents; D010080:Oxazoles; D011422:Propionates; D010653:Phenylbutazone; D001241:Aspirin; D001920:Bradykinin; D007213:Indomethacin